Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDApimeds Pharmaceuticals US Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2025 | Q3 2025 | N/A | -$0.14 | N/A | N/A | $0 |
| 08/19/2025 | Q2 2025 | N/A | -$0.26 | N/A | N/A | $0 |
| 03/31/2025 | Q1 2025 | N/A | -$0.03 | N/A | N/A | $0 |
| 12/31/2024 | Q4 2024 | N/A | -$0.03 | N/A | N/A | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$0.03 | N/A | N/A | $0 |
| 06/30/2024 | Q2 2024 | N/A | -$0.04 | N/A | N/A | $0 |
| 03/31/2024 | Q1 2024 | N/A | -$0.03 | N/A | N/A | $0 |
| 12/31/2023 | Q4 2023 | N/A | -$0.05 | N/A | N/A | $0 |
| 09/30/2023 | Q3 2023 | N/A | -$0.01 | N/A | N/A | $0 |
| 06/30/2023 | Q2 2023 | N/A | -$0.00 | N/A | N/A | $0 |
| 03/31/2023 | Q1 2023 | N/A | -$0.01 | N/A | N/A | $0 |
| 12/31/2022 | Q4 2022 | N/A | -$0.01 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Apimeds Pharmaceuticals US Inc. Earnings: FAQ's
The conference call for Apimeds Pharmaceuticals US Inc.'s latest earnings report can be listened to online.
The conference call transcript for Apimeds Pharmaceuticals US Inc.'s latest earnings report can be read online.
Apimeds Pharmaceuticals US Inc. (:APUS) has a recorded net income of $-1,389,990.Apimeds Pharmaceuticals US Inc. has generated $-0.12 earnings per share over the last four quarters.
Apimeds Pharmaceuticals US Inc. (:APUS) has a price-to-earnings ratio of -3.1 and price/earnings-to-growth ratio is 0.1.